Sheffield Medical Technologies Inc. other research news

SHM (New York, N.Y.) announced publication of the identity of the protein responsible for the activity of UGIF, a candidate for controlling the excess growth of cells in the prostate gland.

As reported in the Journal of Biological Chemistry, biological properties of the protein were identical to previously characterized UGIF activity. ...